• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ERIKA DE REYNOSA, S.A. DE C.V. COMBI SET; SET, TUBING, BLOOD, WITH AND WITHOUT ANTI-REGURGITATION VALVE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ERIKA DE REYNOSA, S.A. DE C.V. COMBI SET; SET, TUBING, BLOOD, WITH AND WITHOUT ANTI-REGURGITATION VALVE Back to Search Results
Model Number 03-2622-3
Device Problem Fluid/Blood Leak (1250)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 05/27/2020
Event Type  malfunction  
Manufacturer Narrative
The plant investigation is in process.A supplemental mdr will be submitted upon completion of this activity.
 
Event Description
The buyer for a hemodialysis (hd) user facility reported to fresenius customer service (cs) that a combi set blood leak occurred during a patient's hd treatment.The buyer was inquiring about replacing their unused combi sets from this lot.Few details were obtained via follow up with a nurse from the user facility.The nurse confirmed there was a bloodline blood leak, but could not provide specific event details.The nurse was unable to recall the date of the event, or the patient involved.It was believed that the leak was coming from the portion of the bloodline tubing close to where the device is connected to the patient.Reportedly, there were no adverse effects experienced by the patient and medical intervention was not required as a result of the event.The nurse stated the patient's treatment was able to be completed after they were re-setup with new supplies.The device was discarded immediately after use and was not available to be returned for evaluation.At this time, no further information has been provided.
 
Manufacturer Narrative
Plant investigation: six cases of companion samples from lot 20ar01099 were returned to the manufacturing plant for evaluation.During the gross visual examination of the returned samples, no irregularities were identified.The arterial and venous patient connectors were closely inspected, and no damages were found.The male conical fitting of the venous and arterial patient connectors were inspected, and dimensionally, they were found to be within tolerance.Functional testing was then performed.One of the companion samples was used in a simulated treatment on a 2008k hemodialysis (hd) machine.For the simulation, the combi set sample was connected to an optiflux f250nr dialyzer filter.During the simulated use test, no leaks were observed at the patient connectors.No air bubbles inside the system were noted, no alarms occurred, and there was no level variation in the venous or arterial chambers.The simulated treatment was completed successfully without complications.A batch records review was conducted by the manufacturer for the reported lot.There were no non-conformances or abnormalities identified during the manufacturing process which could be associated with the reported event.The entire lot has been sold and distributed.In addition, a device history review was performed and confirmed that the results of the in-progress and final quality control (qc) testing met all requirements.The lot met all specifications for release.A product history review did not reveal a probable cause for the customer complaint.Upon completion of the evaluation, there were no malfunctions that could have caused or contributed to the reported event.The combi set sample performed as designed and an associated cause could not be determined.
 
Manufacturer Narrative
Plant investigation: as the device was not returned to the manufacturer, a physical evaluation could not be performed.A batch records review was conducted by the manufacturer for the reported lot.There were no non-conformances or abnormalities identified during the manufacturing process which could be associated with the reported event.The entire lot has been sold and distributed.In addition, a device history review was performed and confirmed that the results of the in-progress and final quality control (qc) testing met all requirements.The lot met all specifications for release.A product history review did not reveal a probable cause for the customer complaint.As a physical evaluation could not be performed, a definitive conclusion regarding the reported incident could not be reached and a cause could not be confirmed.
 
Manufacturer Narrative
The plant investigation is in process.A supplemental mdr will be submitted upon completion of this activity.
 
Event Description
The buyer for a hemodialysis (hd) user facility reported to fresenius customer service (cs) that a combi set blood leak occurred during a patient's hd treatment.The buyer was inquiring about replacing their unused combi sets from this lot.Few details were obtained via follow up with a nurse from the user facility.The nurse confirmed there was a bloodline blood leak, but could not provide specific event details.The device was discarded immediately after use and was not available to be returned for evaluation.Additional details were later provided by the nurse from the user facility.The nurse confirmed blood was observed leaking from the tubing of the combi set, below where the bloodline connects to the patient.There were no reports of visible damage (e.G.A pinhole or cut) at the site of the leak.There were no machine alarms.The patient was dialyzing on a fresenius 2008t machine and was utilizing an optiflux f250nre dialyzer.The patient¿s estimated blood loss (ebl) was minimal.The nurse stated the ebl was approximately 15 ml.It was confirmed there was no patient injury, no adverse effects were experienced, and no medical intervention was required as a result of the reported event.The patient completed their treatment after being re-setup with new supplies on the same machine.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
COMBI SET
Type of Device
SET, TUBING, BLOOD, WITH AND WITHOUT ANTI-REGURGITATION VALVE
Manufacturer (Section D)
ERIKA DE REYNOSA, S.A. DE C.V.
mike allen #1331
parque industrial reynosa
reynosa 88780
MX  88780
MDR Report Key10268047
MDR Text Key200235024
Report Number8030665-2020-00972
Device Sequence Number1
Product Code FJK
UDI-Device Identifier00840861100231
UDI-Public00840861100231
Combination Product (y/n)N
PMA/PMN Number
K962081
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional,user faci
Type of Report Initial,Followup,Followup,Followup
Report Date 11/07/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received07/13/2020
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date01/31/2023
Device Model Number03-2622-3
Device Catalogue Number03-2622-3
Device Lot Number20AR01099
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer07/28/2020
Device AgeMO
Date Manufacturer Received11/05/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
FRESENIUS 2008T MACHINE; FRESENIUS OPTIFLUX F250NRE DIALYZER
Patient Age47 YR
Patient Weight98
-
-